HALEY TIPPIN: Open Payments
NPI 1780033605 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 47 payments from 8 companies in 2025. Trend: 2023 $510 · 2024 $892 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $326 |
| Gilead Sciences, Inc. | 19 | $311 |
| Ipsen Biopharmaceuticals, Inc | 9 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, LIVTENCITY, OCALIVA, Livmarli, MAVYRET.
Industry payments across OK — which companies pay providers there.
